Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00695214 · ClinicalTrials.gov registry record · Phase 2
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
A Phase 2 study of Sleep Apnea, Obstructive, sponsored by University of California, Los Angeles.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 800
- Enrollment target
- 1
- Study location
NCT00695214 is a Phase 2 study of Sleep Apnea, Obstructive that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 800 participants, above the 245-participant average among 45 other Sleep Apnea, Obstructive trials with a reported enrollment target (227% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00695214, a Phase 2 study of Sleep Apnea, Obstructive, is actively recruiting participants, sponsored by University of California, Los Angeles.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 800 participants
- Enrollment target
- 1
- Study location
Study Summary
Prospective, interventional cohort study of drug-induced sleep endoscopy (DISE) to evaluate the upper airway in a cohort of obstructive sleep apnea (OSA) surgical patients. This study has investigated the reliability of this technique, demonstrating moderate-substantial interrater and test-retest reliability. This research has also compared DISE findings to those of the lateral cephalogram X-ray and examined DISE findings in individuals who have not responded to previous sleep apnea surgery. These papers have been published and available through PubMed. Additional research is ongoing, with examination of DISE findings, comparison to other evaluation techniques, and the association between DISE findings and surgical outcomes.
Conditions Studied
Interventions
- DRUG Propofol sedation
Study Locations (1)
California
- UCLA Santa Monica Medical Center - Santa Monica
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2004-02 |
| Est. Completion | 2030-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00695214
The ClinicalTrials.gov registry entry for NCT00695214 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 245-participant average among 45 other Sleep Apnea, Obstructive trials with a reported enrollment target (227% higher). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sleep Apnea, Obstructive appearing as the primary indexed condition, and to 1 intervention - of which Propofol sedation is the first listed.
NCT00695214 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00695214 about?
NCT00695214 is a clinical study titled "Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea". Prospective, interventional cohort study of drug-induced sleep endoscopy (DISE) to evaluate the upper airway in a cohort of obstructive sleep apnea (OSA) surgical patients. This study has investigated the reliability of this technique, demonstrating moderate-substantial interrater and test-retest re...
What is the current status of trial NCT00695214?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 800 participants. The study started on 2004-02. Estimated completion is 2030-06.
What conditions does trial NCT00695214 study?
This clinical trial studies the following conditions: Sleep Apnea, Obstructive.
What interventions are being tested in trial NCT00695214?
The interventions under investigation include: Propofol sedation (DRUG).
Who is sponsoring clinical trial NCT00695214?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00695214 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Apnea, Obstructive
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Do Endotypes Predict Response and Sequelae in OSA Patients
RECRUITING · Phase 2
-
Effect of Desipramine on Upper Airway Collapsibility and Genioglossus Muscle Activity in Patients With Obstructive Sleep Apnea - Study B
COMPLETED · Phase 2
-
Safety of Ramelteon in Subjects With Mild to Moderate Obstructive Sleep Apnea
COMPLETED · Phase 2
-
Nasal vs Oral Breathing in Drug Induced Sleep vs Natural Sleep
RECRUITING
-
The PREDICTOR Study: Assessing Diagnostic Predictors of Airway Collapse in Patients With Obstructive Sleep Apnea
RECRUITING · NA
-
Benefits of Oxytocin in Obstructive Sleep Apnea (OSA) Patients Using Continuous Positive Airway Pressure (CPAP) Machine
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.